← FDA Drug Approvals (Drugs@FDA)

DOXEPIN HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2026-04-28

Drug application

FDA Application #
ANDA213919
Application type
Abbreviated New Drug Application (Generic)
Brand name
DOXEPIN HYDROCHLORIDE
Generic name
Doxepin Hydrochloride
Active ingredients
DOXEPIN HYDROCHLORIDE
Dosage form
CREAM
Route
TOPICAL
Marketing status
Prescription
Sponsor
SUN PHARMA CANADA
First approval
2026-04-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown